⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGVN News
Longeveron Inc. Common Stock
The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
globenewswire.com
LLY
NVO
VKTX
LGVN
Form 8-K
sec.gov
LGVN
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
prnewswire.com
VRTX
OCGN
LGVN
LCTX
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
globenewswire.com
LGVNR
LGVN
Form 8-K
sec.gov
LGVN
Form 8-K
sec.gov
LGVN
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
globenewswire.com
FBLG
FATE
MESO
LGVN
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
prnewswire.com
MESO
LGVN
LCTX
MNKD
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
globenewswire.com
LGVNR
LGVN
Form 8-K
sec.gov
LGVN